Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-16 Sale | 2026-03-18 5:18 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 107,250 | $50.24 | $5,388,432 | 56,544 (Direct) | View |
| 2026-03-13 Sale | 2026-03-16 4:08 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 35,000 | $50.37 | $1,763,124 | 2,224,244 (Indirect Direct) | View |
| 2026-03-12 Sale | 2026-03-16 4:07 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 5,369 | $50.61 | $271,725 | 60,413 (Direct) | View |
| 2026-03-09 Sale | 2026-03-10 4:13 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 1,623 | $53.65 | $87,074 | 18,440 (Direct) | View |
| 2026-03-09 Sale | 2026-03-10 4:12 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Horich William Todd SVP, Commercial Operations | 8,877 | $54.5 | $483,797 | 0 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 4:06 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 18,787 | $53.38 | $1,002,811 | 27,277 (Direct) | View |
| 2026-02-19 Sale | 2026-02-23 4:39 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 4,475 | $51.01 | $228,265 | 0 (Direct) | View |
| 2025-12-19 Sale | 2025-12-22 4:04 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 20,000 | $50.41 | $1,008,150 | 15,496 (Direct) | View |
| 2025-12-18 Sale | 2025-12-19 4:05 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 710 | $44.44 | $31,552 | 14,508 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-16 Exercise | 2026-03-18 5:18 pm | N/A 2029-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 107,250 | $0 | 56,544 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 5:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 35,000 | $36.75 | 56,544 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 5:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 4,250 | $29.61 | 56,544 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 5:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 5,000 | $27.94 | 56,544 (Direct) | View |
| 2026-03-17 Exercise | 2026-03-18 5:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 30,000 | $39.4 | 56,544 (Direct) | View |
| 2026-03-17 Exercise | 2026-03-18 5:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 15,000 | $38.6 | 56,544 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 5:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 18,000 | $32.2 | 56,544 (Direct) | View |
| 2026-03-13 Other | 2026-03-16 4:08 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 12,500 | $0 | 2,224,244 (Direct) | View |
| 2026-03-06 Exercise | 2026-03-10 4:13 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 38,640 | $0 | 2,234,244 (Direct) | View |
| 2026-03-06 Tax Withholding | 2026-03-10 4:13 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 16,574 | $54.73 | 2,234,244 (Direct) | View |
| 2026-03-06 Exercise | 2026-03-10 4:13 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 3,750 | $0 | 18,440 (Direct) | View |
| 2026-03-06 Tax Withholding | 2026-03-10 4:13 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 1,793 | $54.73 | 18,440 (Direct) | View |
| 2026-03-06 Exercise | 2026-03-10 4:12 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 6,000 | $0 | 8,232 (Direct) | View |
| 2026-03-06 Tax Withholding | 2026-03-10 4:12 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 2,883 | $54.73 | 8,232 (Direct) | View |
| 2026-03-06 Exercise | 2026-03-10 4:12 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Horich William Todd SVP, Commercial Operations | 7,500 | $0 | 0 (Direct) | View |
| 2026-03-06 Tax Withholding | 2026-03-10 4:12 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Horich William Todd SVP, Commercial Operations | 3,455 | $54.73 | 0 (Direct) | View |
Ownership | 2026-03-10 4:11 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Horich William Todd SVP, Commercial Operations | 0 | $0 | 167,957 (Direct) | View |
| 2026-03-06 Exercise | 2026-03-09 4:06 pm | 2018-02-24 2027-02-24 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 7,905 | $0 | 27,277 (Direct) | View |
| 2026-03-06 Exercise | 2026-03-09 4:06 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 7,905 | $25.3 | 27,277 (Direct) | View |
| 2026-02-28 Option Award | 2026-03-03 4:12 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 38,640 | $0 | 38,640 (Direct) | View |
| 2026-02-28 Option Award | 2026-03-03 4:11 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 6,000 | $0 | 6,000 (Direct) | View |
| 2026-02-28 Option Award | 2026-03-03 4:09 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 3,750 | $0 | 3,750 (Direct) | View |
| 2026-02-25 Tax Withholding | 2026-02-26 4:19 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 977 | $50.69 | 19,981 (Direct) | View |
| 2026-02-25 Option Award | 2026-02-26 4:19 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 1,875 | $0 | 19,981 (Direct) | View |
| 2026-02-25 Tax Withholding | 2026-02-26 4:19 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 1,279 | $50.69 | 7,615 (Direct) | View |
| 2026-02-25 Option Award | 2026-02-26 4:19 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 2,500 | $0 | 7,615 (Direct) | View |
| 2026-02-25 Tax Withholding | 2026-02-26 4:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 650 | $50.69 | 18,294 (Direct) | View |
| 2026-02-25 Option Award | 2026-02-26 4:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,250 | $0 | 18,294 (Direct) | View |
| 2026-02-25 Tax Withholding | 2026-02-26 4:17 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 675 | $50.69 | 14,591 (Direct) | View |
| 2026-02-25 Option Award | 2026-02-26 4:17 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,250 | $0 | 14,591 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-25 5:22 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 1,766 | $50.86 | 13,269 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-25 5:22 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 603 | $51.35 | 13,269 (Direct) | View |
| 2026-02-24 Option Award | 2026-02-25 5:22 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 4,625 | $0 | 13,269 (Direct) | View |
| 2026-02-24 Option Award | 2026-02-25 4:57 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 4,475 | $0 | 124,119 (Direct) | View |
| 2026-02-24 Option Award | 2026-02-25 4:56 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 4,475 | $0 | 65,782 (Direct) | View |
| 2026-02-24 Option Award | 2026-02-25 4:56 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 4,475 | $0 | 27,045 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-25 4:55 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,000 | $50.86 | 22,319 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-25 4:55 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 581 | $51.35 | 22,319 (Direct) | View |
| 2026-02-24 Option Award | 2026-02-25 4:55 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,125 | $0 | 22,319 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-25 4:54 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 1,038 | $50.86 | 23,083 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-25 4:54 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 603 | $51.35 | 23,083 (Direct) | View |
| 2026-02-24 Option Award | 2026-02-25 4:54 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 3,125 | $0 | 23,083 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-25 4:51 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 369 | $50.86 | 18,641 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-25 4:51 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 671 | $0 | 18,641 (Direct) | View |
| 2026-02-24 Tax Withholding | 2026-02-25 4:51 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 603 | $51.35 | 18,641 (Direct) | View |
| 2026-02-24 Option Award | 2026-02-25 4:51 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 3,125 | $0 | 18,641 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 4:36 pm | 2017-03-01 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 15,000 | $0 | 38,159 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 4:36 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 15,000 | $12.98 | 38,159 (Direct) | View |
| 2026-02-24 Option Award | 2026-02-25 4:36 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 4,475 | $0 | 38,159 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-23 4:39 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 4,475 | $0 | 0 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:49 pm | N/A 2036-02-18 | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 20,500 | $0 | 22,138 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:48 pm | N/A 2036-02-18 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 16,500 | $0 | 31,400 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:47 pm | N/A 2036-02-18 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 16,500 | $0 | 27,784 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:46 pm | N/A 2036-02-18 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 16,500 | $0 | 32,224 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:46 pm | N/A 2036-02-18 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 341,610 | $0 | 341,610 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:45 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 7,966 | $0 | 7,966 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:44 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 7,966 | $0 | 7,966 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:43 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 7,966 | $0 | 7,966 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:40 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 7,966 | $0 | 7,966 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:39 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 7,966 | $0 | 7,966 (Direct) | View |
| 2026-01-09 Exercise | 2026-01-12 4:09 pm | 2017-03-01 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 15,000 | $0 | 61,307 (Direct) | View |
| 2026-01-09 Exercise | 2026-01-12 4:09 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 15,000 | $12.98 | 61,307 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-22 4:04 pm | N/A 2028-02-14 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 20,000 | $0 | 15,496 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-22 4:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 15,000 | $25.3 | 15,496 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-22 4:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 5,000 | $39.4 | 15,496 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-19 4:05 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,500 | $0 | 14,508 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 6:16 pm | 2017-03-01 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 15,000 | $0 | 119,644 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 6:16 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 15,000 | $12.98 | 119,644 (Direct) | View |
| 2025-11-13 Option Award | 2025-11-17 08:54 am | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,500 | $0 | 15,218 (Direct) | View |